Tyrosine Kinase Inhibitors Seem Safe in CML With CKD
In these patients, no further decline in GFR, regardless of TKI used
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
In these patients, no further decline in GFR, regardless of TKI used
Only registered members have full access to PracticeUpdate content.